James R. Abrahamson - 03 Mar 2022 Form 4 Insider Report for CorePoint Lodging Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Mar 2022, 15:31:24 UTC
Prior SEC filing
03 Jan 2022
Next SEC filing
09 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark M. Chloupek, as Attorney-in-fact

Key filing fact

James R. Abrahamson filed Form 4 for CorePoint Lodging Inc. on 07 Mar 2022.

Key facts

  • This page summarizes James R. Abrahamson's Form 4 filing for CorePoint Lodging Inc..
  • 5 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 07 Mar 2022, 15:31.

Change

  • Previous filing in this sequence was filed on 03 Jan 2022.
  • Current net transaction value: -$1,250,930.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CPLG transaction

Common Stock

Disposed to Issuer

Transaction value
$66,486
Shares
-4,158
Change %
-100%
Price
$15.99
Shares after
0
Date
03 Mar 2022
Ownership
Direct
Footnotes
F1, F2
CPLG transaction

Common Stock

Disposed to Issuer

Transaction value
$438,462
Shares
-27,421
Change %
-100%
Price
$15.99
Shares after
0
Date
03 Mar 2022
Ownership
By Trust
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CPLG transaction Derivative

Restricted Stock Unit

Disposed to Issuer

Transaction value
$382,545
Shares
-23,924
Change %
-100%
Price
$15.99
Shares after
0
Date
03 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,924
Exercise price
Footnotes
F1, F4, F5, F6
CPLG transaction Derivative

Deferred Stock Unit

Disposed to Issuer

Transaction value
$203,041
Shares
-12,698
Change %
-100%
Price
$15.99
Shares after
0
Date
03 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,698
Exercise price
Footnotes
F1, F4, F5, F7
CPLG transaction Derivative

Restricted Stock Unit

Disposed to Issuer

Transaction value
$160,396
Shares
-10,031
Change %
-100%
Price
$15.99
Shares after
0
Date
03 Mar 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,031
Exercise price
Footnotes
F1, F4, F5, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

James R. Abrahamson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

On March 3, 2022, Cavalier Acquisition Owner LP ("Cavalier") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, by and among the Issuer, Cavalier (as assignee of Cavalier Acquisition JV LP) and Cavalier MergerSub LP, a Delaware limited partnership and a wholly owned subsidiary of Cavalier (as assignee of Cavalier) ("Merger Sub") dated as of November 6, 2021 (as amended, modified or assigned, the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with Merger Sub surviving such merger as a wholly owned subsidiary of Cavalier (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $15.99 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding tax.

Footnote F2

Includes deferred stock units ("DSUs"). Pursuant to the Merger Agreement, each DSU became immediately vested and cancelled and entitled the holder to receive an amount of cash equal to the number of shares of Common Stock subject to such DSU, as applicable, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration.

Footnote F3

Reflects securities held by a trust for the benefit of the Reporting Person's family, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the shares held by such trust, except to the extent of his pecuniary interest therein.

Footnote F4

Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee.

Footnote F5

Pursuant to the Merger Agreement, each restricted stock unit ("RSU") and DSU became immediately vested and cancelled and entitled the holder to receive an amount of cash equal to the number of shares of Common Stock subject to such RSU or DSU, as applicable, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration.

Footnote F6

Represents RSUs granted in 2020 that were fully vested in 2021, and were scheduled to be settled upon earliest to occur of (i) a change in control, (ii) the date of the Reporting Person's termination or (iii) the date of the Issuer's 2023 annual stockholders' meeting (and in no event later than July 1, 2023).

Footnote F7

Represents DSUs issued to the Reporting Person in 2020 which were fully vested as of the date of grant and were to be settled upon the earliest to occur of (i) a change in control, (ii) the date of the Reporting Person's termination or (iii) the date of the Issuer's 2023 annual stockholders' meeting (and in no event later than July 1, 2023).

Footnote F8

Represents RSUs granted in 2021, which were originally scheduled to vest in full on the earliest to occur of (i) May 20, 2022, (ii) the date of the Issuer's 2022 annual stockholders' meeting, (iii) the date of the Reporting Issuer's termination as a result of death or disability, or (iv) a change in control.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .